Keywords
monoclonal antibodies
immunohistochemistry
How to Cite
Abstract
Since 1996, the Laboratory of Monoclonal Antibodies Antigens and Adjuvants - Immunology Center of Adolfo Lutz Institute (IC-IAL) has been working on N. meningitidis strains antigens characterization by using a predetermined monoclonal antibodies (MoAb) panel; and the new monoclonal production has been performed for characterizing strains with unknown profiles. MoAb were obtained from different fusions performed at IAL using spleen cells and popliteal lymph nodes. Two murine hybridomas secreting MoAb anti-N. meningitidis antigens, produced and characterized in the Laboratory of IC-IAL, are presently being evaluated by immunohistochemical (IHC) technique at Immunohistochemistry Laboratory - Pathology Center, IAL. After standardizing these reactions, a protocol for performing investigation on N.meningitidis antigens by using IHQ was established. An increment in the histopathological diagnosis of meningococcal meningitis was occurred, by using MoAb specific for antigens from N. meningitidis serogroups, serotypes and subtypes, mainly in those cases without microorganisms confirmation by biomolecular techniques as PCR. The results obtained in these first tests proved to be promising, and two MoAb showed excellent results. No cross-reactivity with viral meningitis, S. pneumoniae, Rickettsia or Rubella was detected. For the further studies, it is fundamental to increase the samples size, including samples from patients with meningococcal meningitis and from individuals infected with other pathogens.References
1. Köhler G, Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495-7.
2. Cordeiro MLS, Silva NLF, Vaz MRF, Nóbrega FFF. Anticorpos monoclonais: implicações terapêuticas no câncer. Rev Saúde Ciência On line. 2014;3(3):252-2.
3. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;27 Suppl 2:B51-63.[DOI: 10.1016/j.vaccine.2009.04.063].
4. De Gaspari E, Zollinger W. Expression of class 5 antigens by meningococcal strains obtained from patients in Brazil and evaluation of two new monoclonal antibodies. Braz J Infect Dis. 2001;5(3):143-53. [DOI: 10.1590/S1413-86702001000300007].
5. Belo EF, Ferraz AS, Coutinho LM, Oliveira AP, Carmo AM, Tunes CF, et al. Production of monoclonal antibodies against Neisseria meningitidis using popliteal lymph nodes and in vivo/in vitro immunization: prevalence study of new monoclonal antibodies in greater São Paulo, Brazil. Hybridoma. 2007;26(5):302-10. [DOI: 10.1089/hyb.2007.0508].
6. Belo EF, Coutinho LM, Ferraz AS, De Gaspari EN. Production of monoclonal antibody to subtype 9 of Neisseria meningitidis and the distribution of this subtype in Brazil. Braz J Infect Dis. 2004;8(6):407-18. [DOI: 10.1590/S1413-86702004000600004].
7. Jay JI, Brunhoeber PS, Smith MH, Williams RR, Sugarman MC, Free HL, et al. Immunohistochemical analysis of the monoclonal antibody 4B5 in breast tissue expressing human epidermal growth factor receptor 4 (HER4). Histopathol. 2013;62(4):563-77. [DOI: 10.1111/his.12024].
8. Böger C, Kalthoff H, Goodman SL, Röcken C. Validation and comparison of anti-αvβ3 and anti-αvβ5 rabbit monoclonal versus murine monoclonal antibodies in four different tumor entities. Appl Immunohistochem Mol Morphol. 2013;21(6):553-60. [DOI: 10.1097/PAI.0b013e318284a03a].
9. Chaves LB, Achkar SM, Silva Ade C, Caporale GM, Cruz PS, Batista AM, et al. Monoclonal antibodies for characterization of rabies virus isolated from non-hematophagous bats in Brazil. J Infect Dev Ctries. 2015;9(11):1238-49.[DOI: 10.3855/jidc.6959].
10. Ferraz AS, Belo EF, Coutinho LM, Oliveira AP, Carmo AM, Franco DL, et al. Storage and stability of IgG and IgM monoclonal antibodies dried on filter paper and utility in Neisseria meningitidis serotyping by Dot-blot ELISA. BMC Infect Dis. 2008;8:30. [DOI: 10.1186/1471-2334-8-30].
11. Alves VAF. Garantia de qualidade em imuno-histoquímica. Manual de Imuno-histoquímica. São Paulo: Sociedade Brasileira de Patologia. 1999, 1-9.
12. Sacchi CT, Fukasawa LO, Gonçalves MG, Salgado MM, Shutt KA, Carvalhanas TR, et al. Incorporation of real-time PCR into routine public health surveillance of Culture Negative Bacterial Meningitidis in São Paulo, Brazil. PLoS One. 2011;6(6):e20675. [DOI: 10.1371/journal.pone.0020675].
13. Guarner J, Greer PW, Whitney A, Shieh WJ, Fischer M, White EH, et al. Pathogenesis and Diagnosis of Human Meningococcal Disease Using Immunohistochemical and PCR Assays. Am J Clin Pathol. 2004;122(5):754-64. [DOI: 10.1309/3489075U03LMK9AE].
14. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal Disease. N Engl J Med. 2001;344(18):1378-88. [DOI:10.1056/NEJM200105033441807].
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2016 Instituto Adolfo Lutz Journal